Lees A - Search Results

1

Parkinsonism and dystonia caused by the illicit use of ephedrone--a longitudinal study.

Selikhova M, Fedoryshyn L, Matviyenko Y, Komnatska I, Kyrylchuk M, Krolicki L, Friedman A, Taylor A, Jäger HR, Lees A, Sanotsky Y. Selikhova M, et al. Among authors: lees a. Mov Disord. 2008 Nov 15;23(15):2224-31. doi: 10.1002/mds.22290. Mov Disord. 2008. PMID: 18785245

2

Posttraumatic tremor without parkinsonism in a patient with complete contralateral loss of the nigrostriatal pathway.

Zijlmans J, Booij J, Valk J, Lees A, Horstink M. Zijlmans J, et al. Among authors: lees a. Mov Disord. 2002 Sep;17(5):1086-8. doi: 10.1002/mds.10203. Mov Disord. 2002. PMID: 12360565

3

Trial of subtherapeutic pergolide in de novo Parkinson's disease.

Grosset K, Grosset D, Lees A; Parkinson's Disease Research Group of the United Kingdom. Grosset K, et al. Among authors: lees a. Mov Disord. 2005 Mar;20(3):363-6. doi: 10.1002/mds.20361. Mov Disord. 2005. PMID: 15580607 Clinical Trial.

4

Smoking-responsive juvenile-onset Parkinsonism.

Hanagasi HA, Lees A, Johnson JO, Singleton A, Emre M. Hanagasi HA, et al. Among authors: lees a. Mov Disord. 2007 Jan;22(1):115-9. doi: 10.1002/mds.21177. Mov Disord. 2007. PMID: 17080433

5

Adherence to antiparkinson medication in a multicenter European study.

Grosset D, Antonini A, Canesi M, Pezzoli G, Lees A, Shaw K, Cubo E, Martinez-Martin P, Rascol O, Negre-Pages L, Senard A, Schwarz J, Strecker K, Reichmann H, Storch A, Löhle M, Stocchi F, Grosset K. Grosset D, et al. Among authors: lees a. Mov Disord. 2009 Apr 30;24(6):826-32. doi: 10.1002/mds.22112. Mov Disord. 2009. PMID: 19191340

6

Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis.

Rohrer JD, Paviour D, Bronstein AM, O'Sullivan SS, Lees A, Warren JD. Rohrer JD, et al. Among authors: lees a. Mov Disord. 2010 Jan 30;25(2):179-188. doi: 10.1002/mds.22946. Mov Disord. 2010. PMID: 20077483 Free PMC article.

7

Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease.

Djamshidian A, Jha A, O'Sullivan SS, Silveira-Moriyama L, Jacobson C, Brown P, Lees A, Averbeck BB. Djamshidian A, et al. Among authors: lees a. Mov Disord. 2010 Oct 15;25(13):2203-10. doi: 10.1002/mds.23247. Mov Disord. 2010. PMID: 20721918 Free PMC article.

8

Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease.

Lees A, Fahn S, Eggert KM, Jankovic J, Lang A, Micheli F, Mouradian MM, Oertel WH, Olanow CW, Poewe W, Rascol O, Tolosa E, Squillacote D, Kumar D. Lees A, et al. Mov Disord. 2012 Feb;27(2):284-8. doi: 10.1002/mds.23983. Epub 2011 Dec 9. Mov Disord. 2012. PMID: 22161845 Clinical Trial.

9

Descending control of muscles in patients with cervical dystonia.

Tijssen MA, Münchau A, Marsden JF, Lees A, Bhatia KP, Brown P. Tijssen MA, et al. Among authors: lees a. Mov Disord. 2002 May;17(3):493-500. doi: 10.1002/mds.10121. Mov Disord. 2002. PMID: 12112196

10

Sweating dysfunction in Parkinson's disease.

Swinn L, Schrag A, Viswanathan R, Bloem BR, Lees A, Quinn N. Swinn L, et al. Among authors: lees a. Mov Disord. 2003 Dec;18(12):1459-63. doi: 10.1002/mds.10586. Mov Disord. 2003. PMID: 14673882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,545 results

Search Page

Filters